Ask Ella
What is ask Ella?
The AI analyst that lives inside your Evaluate product.
Ask Ella is built into your Evaluate solution – it understands the specific data, structure, and intelligence of the Evaluate product you already use, so the answers it gives you are grounded in exactly the data you know and trust.
Ask a question in plain English:
Get a sourced, citable answer — fast enough to use in a live meeting....
How Ella helps you
Unlock more value from your current Evaluate solution, faster than ever.
Ella is a new capability integrated into your Evaluate product. All answers come exclusively from the licensed datasets you already trust - not the web or unverified sources.
Licensed data. Every answer sourced.
Results trace back to the underlying Evaluate record. Auditable, citable, and ready to share – without a validation step.
Built for pharma intelligence, not for everything.
Ella understands indications, modalities, deal structures, and forecast models. Ask in plain English – no prompt engineering.
Context that carries through the conversation.
Drill down without starting over. Ella holds your full conversation so you can answer a question in a live meeting and follow up instantly.
Ask a question. Get an answer. Cite it. Act on it.
Ask Ella is the only AI assistant that combines generative AI reasoning with Evaluate proprietary data giving you answers you can stand behind.
"Ask Ella has changed how we prepare. The answers are sourced, the data is the same Evaluate data we trust, and I can drop the output straight into a board deck."
Forecast with confidence
Access peak sales projections, CAGR and consensus models by drug, indication or therapy area. Get the number you in in the time it takes to ask.
ASK A QUESTION
What was the historical forecasted sales from 2020 to 2024 for Keytruda? What are the total forecasted sales by indication for oncology drugs in 2032? Show sales forecast for Pfizer's products indicated for bladder cancer.
Screen assets. Benchmark deals. Move faster.
Interrogate asset values, deal structures, and risk profiles across the market. Ella helps you prioritize opportunities without trawling through reports.
ASK A QUESTION
What are the deal benchmarks for Phase 2 oncology assets in the last 3 years? Which assets in NSCLC have upfront payments above $500m? Show me deal activity for ADC assets in 2023–2024.
Prioritize with the full picture.
Explore investment priorities, portfolio gaps, and therapy area exposure across your assets and the market. Ella turns strategic questions into structured answers.
ASK A QUESTION
What are Merck's lead assets by current year sales across regions? Where are the biggest unmet need gaps in hematology by forecast value? Compare our pipeline coverage vs. Bristol Myers Squibb in oncology.
Know the field before the meeting
Map pipeline strength, upcoming launches, and therapy area share across competitors. Ella gives you the competitive picture in a single conversation.
ASK A QUESTION
Which companies have the most advanced pipeline assets for melanoma? Who are the top competitors in NSCLC by Phase 3 pipeline strength? What are the expected launch timelines for PD-1 assets in solid tumors?
ASK ELLA DEMO
Discover how Ask Ella turns complex questions into clear, sourced answers
Real questions. Under a minute.
What was the historical forecasted sales data from 2020 to 2024 for Keytruda?
- What are the total forecasted sales by indication for oncology drugs in 2032?
- Which companies have the most advanced pipeline assets for melanoma and their expected launch timelines?
- What are the lead assets of Merck based on their current year sales in different regions?
- Show sales forecast for Pfizer’s products indicated for bladder cancer.
- What was the historical forecasted sales data from 2020 to 2024 for Keytruda?
- What are the total forecasted sales by indication for oncology drugs in 2032?
- What are the lead assets of Merck based on their current year sales in different regions?
- Which companies have the most advanced pipeline assets for melanoma and their expected launch timelines?
- Show sales forecast for Pfizer’s products indicated for bladder cancer.
Ask a question.
Get an answer.
Act on it.
"Ask Ella gave me an answer I'd normally spend half a day pulling together and I could cite every number in the same breath."
Frequently Asked Questions
Who can access Ask Ella?
Ask Ella is available to current Evaluate subscribers. Access is built into your existing product -there is no separate login or additional platform to onboard. If you’re unsure whether your subscription includes Ella, contact your account manager.
Which Evaluate products include Ask Ella?
Ask Ella is currently available within Evaluate Pharma and Biomedtracker. Availability is expanding – ask your account manager or customer success manager about your product.
Where does Ella get answers from?
Every answer is sourced from the licensed datasets inside your Evaluate product. Ella does not search the web or synthesizse unverified sources. Results trace back to the underlying Evaluate record and are fully auditable.
How do I get started?
If Ella is already part of your subscription, you’ll find her inside your Evaluate product. If you’d like to find out more or request a demo, use the form above.
